
Research Roundup: Lupus protein identified, vaccine for Type 1 diabetes, new chronic pain treatment, andmore!
Research Roundup: Lupus protein identified, vaccine for Type 1 diabetes, new chronic pain treatment, andmore!
Welcome to this weeks Research Roundup. These Friday posts aim to inform our readers about the many stories that relate to animal research each week. Do you have an animal research story we should include in next weeks Research Roundup? You can send it to us via our Facebook page or through the contact form on the website.
A protein that may cause Lupus has been identified. Lupus is a chronic inflammatory disease that occurs when your bodys immune system attacks its own tissues and organs. An estimated 1.5 million Americans , and at least 5 million people worldwide, have a form of lupus. Previous research has implicated the gene PRDM1 as a risk factor for lupus. Scientists looking at Blimp-1 , a protein that is encoded by the PRDM1 gene, have found in mice that that a low level of or no Blimp-1 in a particular cell type led to an increase in the protein cathepsin S (CTSS) which caused the immune system to identify healthy cells as something to attack particularly in females. These results are particularly striking as women have an increased risk for lupus compared to men. While this work needs to be replicated and validated, this research provides some valuable insight into the etiology and treatment of lupus. This research was published in the journal Nature Immunology .
Mice from the Lupus study. Source: AJP Renal Physiology.
Vaccine for virus induced Type 1 diabetes successful in mice. Coxsackie B viruses are the most common enteroviruses and are believed
Continue
reading